The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
University of Colorado, Denver · with Agency for Healthcare Research and Quality (AHRQ), Seattle Children's Hospital · NCT05832307
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 6 mo–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 22000
- US sites recruiting
- 2
- Study start
- October 31, 2024
- Record last updated
- April 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
Being studied: Existing Influenza Vaccination Practices; Standardized inpatient influenza vaccination program
Conditions: Influenza
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- At least 6 months of age
- Admitted to an inpatient unit at a participating health system
Exclusion
- Admission to critical care sites or hematology-oncology services
Exclusion Criteria
- At least 6 months of age
- Admitted to an inpatient unit at a participating health system
Exclusion
- Admission to critical care sites or hematology-oncology services
Recruiting US locations
Ann and Robert Lurie's Children Hospital of Chicago
Chicago, IL 60611
Site contact: Ravi Jhaveri, MD · 312-227-4080 · rjhaveri@luriechildrens.org
Seattle Children's Hospital
Seattle, WA 98105
Site contact: Annika Hofstetter, MD, PhD, MPH · 205-884-1699 · annika.hofstetter@seattlechildrens.org
Study contacts (from the official record)
- Suchitra Rao · 7207772823 · suchitra.rao@childrenscolorado.org
Similar studies in Illinois
All vaccine studies in Illinois →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Oak Brook, IL + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pfizer
- Location
- Moline, IL + 101 other US sites
- Eligibility basics
- Ages 1 mo–7 mo
- RecruitingHealthy volunteersPhase 4
Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19
Sanofi
- Location
- Melrose Park, IL + 19 other US sites
- Eligibility basics
- Ages 12+